These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31569468)

  • 1. Perioperative Cardioprotection by Remote Ischemic Conditioning.
    Cho YJ; Kim WH
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of non-coding RNAs and extracellular vesicles in cardioprotection by remote ischemic conditioning of the heart.
    Bartekova M; Jelemensky M; Dhalla NS
    Rev Cardiovasc Med; 2019 Jun; 20(2):59-71. PubMed ID: 31344998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection by remote ischemic conditioning and its signal transduction.
    Kleinbongard P; Skyschally A; Heusch G
    Pflugers Arch; 2017 Feb; 469(2):159-181. PubMed ID: 27928644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
    Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
    Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
    Vinten-Johansen J; Shi W
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
    Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
    Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.
    Xiong J; Liao X; Xue FS; Yuan YJ; Wang Q; Liu JH
    Chin Med J (Engl); 2011 Jul; 124(14):2209-15. PubMed ID: 21933628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
    Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conditioning the heart in cardiac surgery].
    Deja MA; Malinowski M
    Kardiol Pol; 2011; 69 Suppl 3():80-4. PubMed ID: 22125208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial remote ischemic preconditioning: from pathophysiology to clinical application.
    Costa JF; Fontes-Carvalho R; Leite-Moreira AF
    Rev Port Cardiol; 2013 Nov; 32(11):893-904. PubMed ID: 24120469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote cardiac ischemic conditioning: underlying mechanisms and clinical applications.
    Gaspar A; Leite-Moreira AF
    Rev Port Cir Cardiotorac Vasc; 2012; 19(4):183-90. PubMed ID: 24490195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Future of Cardioprotection-Pointing Toward Patients at Elevated Risk as the Target Populations.
    Bøtker HE
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):487-493. PubMed ID: 32597205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin in ischemic conditioning-induced tissue protection: Evidences and possible mechanisms.
    Sharma R; Randhawa PK; Singh N; Jaggi AS
    Eur J Pharmacol; 2015 Dec; 768():58-70. PubMed ID: 26499976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.
    Przyklenk K
    Drugs Aging; 2011 May; 28(5):331-43. PubMed ID: 21542657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.